torso
TOR protein is uniformly expressed along the surface membrane of early
embryos despite its localized activity at both poles. Polarized
activity of this protein depends on other terminal gene functions, one of which may be a localized
extracellular ligand generated during oogenesis. Different levels of active TOR protein can specify
distinct portions of the terminal pattern. Thus, TOR functions as a ubiquitous
surface receptor that is activated by a spatially restricted ligand. Localized activity of the
TOR kinase may generate one or more gradients of intracellular signals that control body pattern (Casanova, 1989).
Early Drosophila development requires two receptor tyrosine kinase (RTK) pathways: the Torso and the Epidermal growth factor receptor (EGFR) pathways, which regulate terminal and dorsal-ventral patterning, respectively. Previous studies have shown that these pathways, either directly or indirectly, lead to post-transcriptional downregulation of the Capicua repressor in the early embryo and in the ovary. This study shows that both regulatory effects are direct and depend on a MAPK docking site in Capicua that physically interacts with the MAPK Rolled. Capicua derivatives lacking this docking site cause dominant phenotypes similar to those resulting from loss of Torso and EGFR activities. Such phenotypes arise from inappropriate repression of genes normally expressed in response to Torso and EGFR signaling. These results are consistent with a model whereby Capicua is the main nuclear effector of the Torso pathway, but only one of different effectors responding to EGFR signaling. Finally, differences in the modes of Capicua downregulation by Torso and EGFR signaling are described, raising the possibility that such differences contribute to the tissue specificity of both signals (Astigarraga, 2007).
The formation of the unsegmented terminal regions of the Drosophila larvae, acron (the terminal head structure including the brain) and telson (the terminal tail structure)
requires the function of at least five maternal genes (terminal genes class). In their absence, the
telson and acron are not formed. One of them, torso, has gain-of-function alleles that have
an opposite phenotype to the lack-of-function (tor-) alleles: the segmented regions of the larval
body, thorax and abdomen, are missing, whereas the acron is not affected and the telson is
enlarged. In strong gain-of-function mutants, the pair-rule gene fushi tarazu (ftz) is not expressed,
demonstrating the suppression of the segmentation process in an early stage of development. The
tor gain-of-function effect is neutralized, and segmentation is restored in double mutants with the
zygotic gene tailless (tll) that has a phenotype similar (but not identical) to that of tor-. This
suggests that TOR acts through tll, and that in the gain-of-function alleles of tor, the TLL gene product is
ectopically expressed in the middle regions of the embryo, where it inhibits the expression of
segmentation genes like ftz (Klingler, 1988).
14-3-3 proteins have been shown to interact with Raf-1 and cause its activation when
overexpressed. However, their precise role in Raf-1 activation is still enigmatic, as
they are ubiquitously present in cells and found to associate with Raf-1 in vivo
regardless of Raf's activation state. The function of the Drosophila
14-3-3 gene leonardo (leo) has been analyzed in the Torso (Tor) receptor tyrosine kinase (RTK)
pathway. In the syncytial blastoderm embryo, activation of Tor triggers the
Ras/Raf/MEK pathway that controls the transcription of tailless (tll). In
the absence of Tor, overexpression of leo is sufficient to activate tll expression. The
effect of leo requires D-Raf and Ras1 activities but not KSR or DOS, two recently
identified essential components of Drosophila RTK signaling pathways. Tor signaling
is impaired in embryos derived from females lacking maternal expression of leo. It is
proposed that binding to 14-3-3 by Raf is necessary but not sufficient for the activation
of Raf and that overexpressed Drosophila 14-3-3 requires Ras1 to activate D-Raf (Li, 1997).
Hypoactivity in torso
results in the loss of the most posterior domain of fushi tarazu expression and the terminal cuticular
structures. In contrast, a torso hyperactivity mutation causes the loss of central fushi tarazu
expression and central cuticular structures. This effect is caused by abnormal persistence of the
Torso product in the central region of the embryo during early development. Thus, the amount and
timing of torso activity is key to distinguishing the central and terminal regions of the embryo.
Mutations in the tailless terminal gene act as dominant maternal suppressors of the hyperactive
torso allele, indicating that the torso product acts through, or in concert with, the tailless product (Strecker, 1989).
Injecting eggs with in vitro synthesized Torso mRNAs
revealed that torso activation is governed by an extracellular molecule
produced at terminal regions of the egg during early embryogenesis. Mutant ligand-binding Torso proteins can suppress telson
formation in a dominant negative manner, suggesting that the ligand is limited in amount. Analysis of
torso mutations indicates that Torso functions as a tyrosine kinase and that gain-of-function
mutations causing ligand-independent activation are located in the extracellular domain (Sprenger, 1992).
Mutations in torso and trunk that express low levels of the respective protein have differential affects on the expression of tailless and huckebein. For example a reduced amount of TRK can trigger signaling of TOR to levels required to activate tll but not hkb. For a given number of TOR receptors, an increase in the amount of TRK results in the appearance of more structures of the most posterior segment (A8) (Furriols, 1996).
hindsight expression in the midgut is controlled by the maternal and zygotic members of the torso mediated terminal pathway. Embryos produced by homozygous torso loss-of-function mutant females lack Hnt protein in the posterior midgut, which lies within the domain of torso function. Instead of extending their germ bands dorsoanteriorly, most such embryos form spiralled germ bands. Reciprocally, embryos carrying torso gain of function mutations lack dorsal expression (that is, in the presumptive amnioserosa), consistent with conversion of central cell fates to more terminal ones. These embryos also show expanded expression of Hnt protein in the enlarged posterior midgut primordium and a twisted gastrulation phenotype (Yip, 1997).
Eight alleles of Dsor1 encoding a Drosophila homolog of mitogen-activated protein (MAP) kinase
kinase were obtained as dominant suppressors of the MAP kinase kinase kinase D-raf. These Dsor1
alleles themselves showed no obvious phenotypic consequences nor any effect on the viability of the
flies, although they were highly sensitive to upstream signals and strongly interacted with
gain-of-function mutations of upstream factors. They suppress mutations for receptor tyrosine
kinases (RTKs) torso, sevenless, and to a lesser extent, Drosophila EGF receptor.
Furthermore, the Dsor1 alleles show no significant interaction with gain-of-function mutations of
Egfr. The observed difference in activity of the Dsor1 alleles among the RTK pathways suggests
Dsor1 is one of the components of the pathway that regulates signal specificity. Expression of Dsor1 in
budding yeast demonstrates that Dsor1 can activate yeast MAP kinase homologs if a proper
activator of Dsor1 is coexpressed. Nucleotide sequencing of the Dsor1 mutant genes reveal that
most of the mutations are associated with amino acid changes at highly conserved residues in the
kinase domain. The results suggest that they function as suppressors due to increased reactivity to
upstream factors rather than constitutive activity (Lim, 1997).
To investigate a Ras-independent means of activating the Mapk cascade, mutations have been isolated that suppress the lethality of a Drosophila Raf mutation [also referred to as l(1) pole hole]. Six extragenic Su(Raf) loci have also been identified. These mutations not only suppress RafC110 but also other partial loss-of-function Raf alleles that do not impair Ras-Raf binding. This suggests that the suppression of RafC110 by the extragenic Su(Raf) mutations does not necessarily involve the restoration of Ras-Raf binding. Developmental analyses have shown that all six extragenic Su(Raf) mutations promote signaling in the Sevenless (Sev) and Egfr RTK pathways. Su(Raf)34B is a gain-of-function mutation in the Dsor1 locus that encodes the fly Mek. Recently, Su(Raf)1 has been shown to encode Src42A. The isolation of mutations that suppress the suppressor activity of Su(Raf)1 is reported in this paper. These mutations define two known genes, Egfr and rolled (rl; also referred to as Mapk) and two previously uncharacterized loci. In addition, two alleles of Src42A were also isolated in the screen, although these mutations are not true suppressors of Su(Raf)1 (Zhang, 1999).
One of the novel suppressor loci was named semang (sag). sag is required during both embryonic and imaginal disc development. Mutations in sag cause zygotic lethality. To identify developmental pathways where sag functions, the phenotypes associated with sag mutations were examined with particular attention to those processes controlled by known Drosophila RTKs. The results of these analyses show that sag participates in the Torso (Tor) and Drosophila DFGF-R1 RTK (Breathless) pathways during embryonic development. sag also disrupts the embryonic peripheral nervous system. During imaginal disc development, sag mutations affect two processes known to require Egfr signaling: the recruitment of photoreceptor cells and wing vein formation. Thus sag functions broadly in several RTK-mediated processes. This role of sag in RTK signaling is further supported by the genetic interaction between sag and other known RTK signaling genes. sag dominantly enhances the phenotypes caused by reductions of RTK signaling in loss-of-function Raf or rl mutants. Consistent with this, sag dominantly suppresses the formation of supernumerary R7 cells caused by the activated sev-Ras1V12 mutation. The sag mutations analyzed are likely to be loss-of-function mutations. These results suggest that sag may have a positive role in RTK signaling (Zhang, 1999).
Focus was placed on processes known to be controlled by RTKs. At the beginning of embryogenesis, the Tor RTK pathway specifies the embryonic terminal cell fates. Activation of Tor at the embryonic poles triggers the Ras-Mapk signaling cascade, resulting in the expression of two transcription factors: tailless (tll) and huckebein (hkb). tll and hkb in turn activate genes required for terminal development. Whenever there are reductions of tll and hkb expression due to reduced levels of Tor signaling, deletions of terminal structures occur. In the absence of Tor, the mutant embryos lack the anterior acron and all structures posterior to abdominal segment seven (A7). In sag homozygote mutant embryos derived from sag GLC eggs crossed to sag heterozygote males, terminal defects similar to those of the RafPB26 allele are observed. The head skeletal structure is collapsed; the tail region contains a partial deletion of the abdominal segment eight; the size of the anal pads is reduced and associated structures appear abnormal. The expressions of tll and hkb at the posterior embryonic pole are solely activated by tor signaling, whereas the anterior expressions are also activated by the bicoid morphogene. In wild-type cellular blastoderm embryos, tll is expressed posteriorly from 0% to 15% egg length (EL; 0% EL is at the posterior pole); hkb is expressed posteriorly from 0% to 9% EL. In sag mutant embryos, posterior tll expression is reduced to 10% EL; posterior hkb expression is reduced to 6% EL. In other words, there is an ~30% reduction of the posterior expressions of both tll and hkb in sag mutants. The anterior expression of these two genes appears grossly normal, with perhaps a slight broadening of tll and a slight reduction of hkb. Consistent with this, the anterior head defect appears variable and is only observed in 50% of the embryos. These results suggest that sag is involved in tor signaling, although the mutation blocks tor signaling to a lesser extent than a Ras1 gene deletion mutation. In embryos lacking maternal Ras1+, the posterior tll expression domain is reduced to 5% EL and hkb is not expressed at the posterior. The residual tll expression in the Ras1 mutant embryos reflects the functioning of the Ras1-independent pathway that activates the Mapk cascade (Zhang, 1999).
Drosophila has two other Src family members, Src64 and Tec29, both of which are involved in ring canal development during oogenesis. Src64 does not affect viability when mutated. The isolation of Su(Raf)1 as a mutation in Src42A that restores the viability of Raf mutants and the isolation of Egfr, rl, and sag as extragenic suppressors of Su(Raf)1 provides the first in vivo evidence that both Src42A and sag are modulators of RTK signaling. At this moment, it is not known where Src42A and sag fit into the known RTK signaling cascade. An Src42A cDNA driven by a ubiquitously expressing promoter rescues the lethality of both Su(Raf)1 homozygotes and Su(Raf)1/Df hemizygotes. Based on this, Su(Raf)1 has loss-of-function characteristics, suggesting that Src42A is, unexpectedly, a negative modulator of RTK signaling. However, the genetics of Su(Raf)1 suggest that the suppression of RafC110 may be attributed to a dominant-interfering effect because the RafC110 lethality is not suppressed in Src42A hemizygotes of genotype Df(2R)nap9/+. Because of this, the role of Src42A in RTK signaling is still being investigated. However, the genetic interaction as revealed by the modifying screen suggests that Egfr and other RTKs may possibly regulate Src42A and sag, which in turn modulate the Mapk cascade (Zhang, 1999).
Transcriptional control of the Drosophila terminal gap gene huckebein (hkb) depends on Torso (Tor) receptor tyrosine
kinase (RTK) signaling and the Rel/NFB homolog Dorsal (Dl). Dl acts as an intrinsic transcriptional
activator in the ventral region of the embryo, but under certain conditions, such as when it is associated with the
non-DNA-binding co-repressor Groucho (Gro), Dl is converted into a repressor. Gro is recruited to the enhancer
element in the vicinity of Dl by sequence-specific transcription factors such as Dead Ringer (Dri). The interplay between Dl, Gro and Dri on the hkb enhancer was examined and it was shown that when acting over a distance, Gro abolishes rather than converts Dl activator function. However, reducing the distance between Dl- and Dri-binding sites switches Dl into a Gro-dependent repressor that overrides activation of transcription. Both of the distance-dependent regulatory options of Gro -- quenching and silencing of transcription -- are inhibited by RTK signaling. These data describe a newly identified mode of function for Gro when acting in concert with Dl. RTK signaling provides a way of modulating Dl function by interfering either with Gro activity or with Dri-dependent recruitment of Gro to the enhancer (Hader, 1999).
The cis-acting element has been identified that mediates expression of the Drosophila gene hkb, which is necessary for terminal pattern formation and to size the mesoderm anlage in the blastoderm embryo. Deletion analysis of this element reveals a 162 base pair (bp) sub-element that integrates the activities of the Tor-dependent RTK signaling cascade and the morphogen Dl. This element, termed hkb ventral element (VE), comprises a 112 bp ventral activator element (VAE) and a 50 bp ventral repressor element (VRE) (Hader, 1999).
The VAE contains a Dl-binding site, identified in vitro, and mediates gene activation along the ventral side of the embryo. VAE-mediated gene expression is absent in embryos lacking Dl activity and extends throughout Toll10b mutants, in which Dl is present in all nuclei of the embryo. The expression pattern is not altered in embryos lacking snail and twist, the zygotic mediators of Dl. It is also not affected in embryos that lack Tor or express constitutively active TorY9, which causes RTK signaling throughout the embryo. In contrast, the VE fails to activate in the absence of Tor and mediates broad ventral expression in torY9 embryos not seen in the absence of Dl activity. This indicates that VAE mediates transcriptional activation by Dl, that the VRE, which by itself fails to activate transcription, is necessary to prevent Dl-dependent activation in the central region of the embryo, and that the activity of the unknown repressor, mediated by the VRE, is relieved by RTK signaling (Hader, 1999).
To investigate whether this action of Gro on Dl is determined by the arrangement of Dri- and Dl-binding sites in the VE, the transcription patterns driven by a modified VE-kni-element were examined in which the normal distance of 91 bp between the binding sites was reduced to 45 bp. This reduction results in Dl-dependent repression along the ventral side of wild-type embryos. Repression is not observed in the absence of Gro or Dl or in embryos expressing the constitutively active TorY9 protein. In contrast, the repression domain expands anteriorly in tor mutant embryos, which lack RTK signaling, and is found to be Dl-dependent. This suggests that the spatial arrangement of the Dl- and Dri-binding sites dictates the mechanism by which Gro and Dl act within the enhancer element. In one case, Dl is suppressed by Gro, in the other, Dl is converted into a potent silencer of transcription that can override activation by Bcd and Cad. Both modes of repression are controlled by Tor-dependent RTK signaling (Hader, 1999).
These results establish that the cooperation between two maternal signaling systems, which determines the spatial limits of the Drosophila mesoderm anlage through hkb expression, is based on the management of the ubiquitously distributed factors Gro and Dri by local RTK signaling and that Gro can act through different modes on Dl. Lack of dead ringer (dri) activity does not result in an overt expansion of hkb expression on the ventral side of the embryo. However, as has been observed for VE-dependent gene expression, it causes only weak defects in mesoderm formation as compared with Gro-deficient embryos or embryos that express hkb under the control of the VAE. Thus, the interactions shown here represent only the Dri-dependent aspect of Gro's effect on hkb expression. The full picture of hkb control is likely to involve additional and redundantly acting factor(s) that recruit Gro to sites flanking the VE within the hkb control region (Hader, 1999).
Overactivation of receptor tyrosine kinases (RTKs) has been linked to tumorigenesis. To understand how a hyperactivated RTK functions differently from wild-type RTK, a genome-wide systematic survey was conducted for genes that are required for signaling by a gain-of-function mutant Drosophila RTK Torso (Tor). Chromosomal deficiencies were screened for suppression of a gain-of-function mutation tor (torGOF); this screen led to the identification of 26 genomic regions that, when in half dosage, suppress the defects caused by torGOF. Testing of candidate genes in these regions revealed many genes known to be involved in Tor signaling (such as those encoding the Ras-MAPK cassette, adaptor and structural molecules of RTK signaling, and downstream target genes of Tor), confirming the specificity of this genetic screen. Importantly, this screen also identified components of the TGFß (Dpp) and JAK/STAT pathways as being required for TorGOF signaling. Specifically, it was found that reducing the dosage of thickveins (tkv), Mothers against dpp (Mad), or STAT92E (aka marelle), respectively, suppress torGOF phenotypes. Furthermore, it has been demonstrated that in torGOF embryos, dpp is ectopically expressed and thus may contribute to the patterning defects. These results demonstrate an essential requirement of noncanonical signaling pathways for a persistently activated RTK to cause pathological defects in an organism (Lia, 2003).
In Drosophila, the gradient of the Bicoid (Bcd) morphogen
organizes the anteroposterior axis while the ends of the
embryo are patterned by the maternal terminal system. At
the posterior pole, expression of terminal gap genes is
mediated by the local activation of the Torso receptor
tyrosine kinase (Tor). At the anterior, terminal gap genes
are also activated by the Tor pathway but Bcd contributes
to their activation. Evidence is presented that Tor and
Bcd act independently on common target genes in an
additive manner. Furthermore, the terminal
maternal system is shown not to be required for proper head
development, since high levels of Bcd activity can
functionally rescue the lack of terminal system activity at
the anterior pole. This observation is consistent with a
recent evolution of an anterior morphogenetic center
consisting of Bcd and anterior Tor function (Schaeffer, 2000).
The terminal maternal system directly modifies Bcd by
phosphorylation at several MAPK sites in a Ser/Thr (S/T)-rich
region located between the homeodomain and the identified
transcriptional activation domains. A deletion variant of Bcd that lacks all these
activation domains but still contains the S/T-rich region
(BcdDeltaQAC) is able to rescue to viability bcd loss-of-function
mutants. Hence, it is conceivable that
the ability of the tor pathway to create negative charges through
phosphorylation of this region of Bcd might result in an acidic-rich
transcriptional activation domain that compensates for the
loss of all the other activation domains. If this were the case,
then the transcriptional activity of the BcdDeltaQAC deletion
variant should be highly dependent on tor function. To test this
hypothesis, the ability of a BcdDeltaQAC transgene to
rescue the bcd phenotype in embryos derived from bcd;tsl
double mutant mothers was assayed. BcdDeltaQAC rescues the bcd phenotype
of the bcd;tsl double mutant similarly to a wild-type bcd
transgene, resulting in a tsl only phenotype. Since
BcdDeltaQAC is functionally independent of the tor pathway, it is
concluded that the terminal system is not responsible for BcdDeltaQAC's
activation potential. This result is also consistent with the
notion that, in transient transfection experiments and
transgenic studies, Bcd transcriptional activity is not
significantly modified by mutations of the putative MAPK
consensus sites. Thus, the described direct modification of Bcd by the tor
pathway does not appear to be necessary for Bcd's function (Schaeffer, 2000).
tor function is necessary to allow a normal expression pattern
of most Bcd target genes: many Bcd target genes such as otd
are expressed in a reduced anterior domain in tor mutants. Furthermore, the expression domain of these
genes is expanded in tor gain-of-function backgrounds, again
suggesting that the tor pathway potentiates Bcd function. This
effect could be direct, as Bcd transcriptional activity might be
enhanced by direct modification of the protein (for instance by
phosphorylation). Alternatively, the effect might be indirect, since
most Bcd target promoters might also be responsive to Tor
through distinct elements (Schaeffer, 2000).
A direct effect should be detectable with simply organized
Bcd target promoters that only contain Bcd-response elements
and no Tor-response elements. The proximal hb promoter (P2)
resembles such a simple Bcd-response element, which uses
activators to set an expression border without the assistance of
repressors. The hb P2 promoter is not directly responsive
to the terminal pathway; in the absence of Tor activity, the
posterior border of hb expression moves only very slightly
towards the anterior and, in tor gain-of-function
embryos (tor4021), the posterior
expression border does not respond significantly to
ubiquitously activated Tor (Schaeffer, 2000).
However, the hb P2 promoter is still 300 bp long and might
contain elements that are not well defined, and the hb pattern
is very dynamic. Therefore, in addition an artificial
Bcd responder gene was used whose promoter elements are all known.
This promoter contains only Bcd and Hb binding sites
(Bcd3Hb3-LacZ), and its
expression is reminiscent of the hb P2 promoter, with an
anterior cap expression domain from 100% to 65% EL. If Bcd were a direct target of
Tor, the posterior border of the reporter gene expression
domain should move in response to a tor gain-of-function
allele. However, the expression pattern does not change in a
tor4021 background. This argues for a Bcd activator
function that is not under direct control of the terminal system. Thus, Bcd and Tor seem to be part of two independent
pathways, which share common target genes (Schaeffer, 2000).
When a complete series of Bcd deletion variants
was assayed for their ability to rescue the bcd loss-of-function phenotype in the absence of terminal system
activity, one transgenic line was found that not only rescues the
bcd phenotype but also the anterior part of the tsl phenotype
(labrum and dorsal bridge), resulting in a posterior terminal
mutant phenotype only. This particular transgenic
line carries a bcd variant that deletes an alanine-rich domain
(BcdDeltaA) and has been shown to activate the bcd
target gene hb in a widely enlarged expression domain. Using Bcd immunostaining, it has been
shown that this transgenic line exhibits levels of Bcd that are
approximately 2- to 3-fold higher than wild type. Since other BcdDeltaA lines did not exhibit the same ability to
rescue the tsl phenotype, it is concluded that the higher
expression level of this particular line rather than the lack of a
specific negative protein element (alanine-rich domain) is
responsible for overcoming the requirement for the terminal
pathway at the anterior (Schaeffer, 2000).
To further address whether high levels of bcd activity are
sufficient to rescue the anterior terminal system phenotype or,
if only a particular Bcd deletion variant is capable thereof, the ability of increased doses of wild-type bcd
transgenes to rescue several terminal mutant backgrounds was tested.
Since the previous experiments were performed with the tsl1
allele, which might only represent a strong hypomorphic allele
rather than a null, another tsl mutant, tsl4 , was included that is
among the strongest in the allelic series, as well as null mutant
alleles of the terminal genes trk and tor. To increase the Bcd
expression level, flies containing an X chromosome
or a third chromosome each carrying two wild-type bcd rescue
constructs were used; these
flies carry up to six copies of bcd. The phenotypes of all
terminal mutants (tsl, trk or tor) are similar: lack of labrum and
dorsal bridge in the anterior and deletion of all structures
posterior to A7. Four copies of the
bcd gene were able to rescue anterior structures including
labrum and dorsal bridge in about 40% of all embryos derived from a tsl4 mutant background,
while the posterior terminal phenotype is unaffected. Six copies of bcd are necessary to obtain the same
anterior rescue in about 15% of all
embryos derived from trk mutants and in about 5%
of all embryos derived from tor mutants. However, not all embryos with rescued labrum
and dorsal bridge had a perfectly aligned head skeleton. This
might be due to incomplete rescue, but it could also be due to
Bcd-mediated overexpression of hb at the anterior pole, which
results in terminal-like phenotypes (Schaeffer, 2000).
Actually 50%, 70% or 85% of the head cuticles of tsl, trk or
tor mutants, respectively, could not be analyzed for rescue due to severe
anterior defects, which seemed more severe than normal
terminal phenotypes. Nonetheless, some of the rescued
embryos (less than 2%) were able to hatch and move around,
which suggests complete anterior rescue. These probably
represent embryos where just enough Bcd was present to
overcome the lack of the terminal system but not too much to
induce the phenotype due to high ectopic expression of hb. All
larvae died within 2 hours, likely due to the posterior terminal
defects. It should be noted that very few embryos exhibited the
type of abdominal segment fusions that have been described
for embryos derived from mothers carrying excess copies of
the bcd gene. This might be
due to the lack of terminal system function at the posterior pole
in these experiments. Since no tail is made, there is probably
more space for fate-map shifts towards the posterior, resulting
in the correct establishment of abdominal segments A1 to A6.
The rescue of the anterior terminal phenotype by high levels
of bcd further indicates that the major role of the anterior
terminal system is the potentiation of Bcd activity (Schaeffer, 2000).
In the posterior region of the embryo, the tor pathway activates
the zygotic effectors tll and hkb, which are sufficient to specify
the most posterior anlagen and the gut of the larva. At the anterior, the function of the terminal system
is more difficult to interpret and, in tor mutants, hkb expression
is only reduced. It actually requires bcd;tsl double mutants to
lose all anterior hkb expression,
which indicates additive functions of the anterior and terminal
systems on this common target gene. hkb seems particularly
interesting in this context, as its function is required for the
formation of the labrum: reduction
of hkb expression, as observed in terminal mutant background leads to the deletion of
this particular structure (Schaeffer, 2000).
Therefore, it was asked whether the rescue of anterior
structures (e.g. the labrum) mediated by high levels of Bcd in
terminal system mutants is correlated with the restoration of
the hkb expression pattern. Expression of hkb is first detected
in the terminal regions (anterior and posterior) of the syncytial
blastoderm. In terminal mutant embryos, the
posterior domain is absent, whereas the anterior domain is reduced. In a tsl background with four
or six copies of bcd, however, hkb expression
extends further towards the posterior. Hence, the level of hkb expression can
be regained by increasing the levels of Bcd in a
terminal system mutant, even though its exact
expression domain cannot be restored. It is likely that fate-map
shifts are able to absorb the slightly
changed expression domain of hkb. This
suggests that the lack of terminal system activity
at the anterior can simply be overcome by
another system through enhancement of
transcriptional activation of common target
genes (Schaeffer, 2000).
Tor has been shown to antagonize Groucho-mediated
repression of genes such as hkb and tll, probably by acting on
the HMG-box transcription factor Capicua. Therefore, it is likely that
Tor enhances Bcd activity by derepression, i.e. the
inactivation of potential repressors of Bcd target genes,
and thereby rendering any transcriptional activator more
potent. As the cis-regulatory control regions of most
developmental genes comprise both repressor and
activator sites, the inactivation of potential repressors
should lead to enhanced expression, or enlarged
expression domains, as observed for several bcd target
genes in a tor gain-of-function background (Schaeffer, 2000).
Andrioli, L. P. M., et al. (2002). Anterior repression of a Drosophila stripe enhancer requires three position-specific mechanisms. Development 129: 4931-4940. 12397102
Astigarraga, S., et al. (2007). A MAPK docking site is critical for downregulation of Capicua by Torso and EGFR RTK signaling.
EMBO J. 26(3): 668-77. Medline abstract: 17255944
Bellaiche, Y., et al. (1996). Neither the homeodomain nor the activation
domain of Bicoid is specifically required for its
down-regulation by the Torso receptor tyrosine
kinase cascade. Development 122, 3499-3508
Casanova, J. and Struhl, G. (1989).
Localized surface activity of torso, a receptor tyrosine
kinase, specifies terminal body pattern in Drosophila. Genes Dev 3: 2025-38
Casanova, J. and Struhl, G. (1993). The torso receptor localizes as well as transduces the
spatial signal specifying terminal body pattern in
Drosophila. Nature 362: 152-5
Casanova, J., et al. (1995). Similarities between trunk and spätzle, putative
extracellular ligands specifying body pattern in
Drosophila. Genes Dev 9: 2539-2544
Casci, T., Vinos, J. and Freeman, M. (1999). Sprouty, an intracellular inhibitor of Ras signaling. Cell 96(5): 655-65.
Cleghon, V., et al. (1996). Drosophila terminal structure development is regulated by the compensatory activities of positive and negative phosphotyrosine signaling sites on the Torso RTK. Genes and Development 10: 566-577
Cockerill, K.A., Billin, A.N. and Poole, S.J. (1993). Regulation of expression domains and effects of ectopic expression reveal gap gene-like properties of the linked pdm genes of Drosophila. Mech Dev. 41: 139-153
de las Heras, J. M. and Casanova, J. (2006). Spatially distinct downregulation of Capicua repression and Tailless activation by the Torso RTK pathway in the Drosophila embryo. Mech. Dev. 123(6): 481-6. 16753285
Finkelstein, R. and Perrimon, N. (1990). The orthodenticle gene is regulated by bicoid and torso
and specifies Drosophila head development. Nature 346: 485-8
Furriols, M., Sprenger, F. and Casanova, J. (1996). Variation in the number of activated torso receptors correlates with differential gene expression. Development 122: 2313-7
Furriols, M., Ventura, G. and Casanova, J. (2007). Two distinct but convergent groups of cells trigger Torso receptor tyrosine kinase activation by independently expressing torso-like. Proc. Natl. Acad. Sci. 104(28): 11660-5. PubMed citation
Gabay, L., Seger, R. and Shilo, B. Z. (1997). MAP kinase in situ activation atlas during Drosophila
embryogenesis. Development 124: 3535-3541.
Gao, Q., Wang, Y. and Finkelstein, R. (1996). orthodenticle regulation during embryonic head
development in Drosophila. Mech. Dev. 56: 3-15
Gayko, U., et al. (1999). Synergistic activities of multiple phosphotyrosine residues
mediate full signaling from the Drosophila Torso receptor
tyrosine kinase. Proc. Natl. Acad. Sci. 96(2): 523-8.
Ghiglione, C., Perrimon, N. and Perkins, L. A. (1999). Quantitative variations in the level of MAPK activity control patterning of the embryonic termini in Drosophila. Dev. Biol. 205(1): 181-93.
Goriely, A., et al. (1996). A functional homologue of goosecoid in Drosophila.
Development 122: 1641-1650
Grossniklaus, U., Cadigan, K. M. and Gehring, W. J. (1994). Three maternal coordinate systems cooperate in the patterning of the Drosophila head. Development 120: 3155-3171
Häcker, U., et al. (1995).
The Drosophila fork head domain protein crocodile is
required for the establishment of head structures. EMBO J 14: 5306-5317.
Hader, T., et al. (1999). Receptor tyrosine kinase signaling regulates different modes of Groucho-dependent control of Dorsal. Curr. Biol. 10: 51-54.
Hou, X. S., et al. (1995). The torso receptor tyrosine kinase can activate Raf in a
Ras-independent pathway. Cell 81: 63-71
Janody, F. Reischl, J. and Dostatni, N. (2000). Persistence of Hunchback in the terminal region of the Drosophila blastoderm
embryo impairs anterior development. Development 127: 1573-1582
Jimenez, G., et al. (2000). Relief of gene repression by torso RTK signaling: role of capicua in Drosophila terminal and
dorsoventral patterning. Genes Dev. 14(2): 224-31.
Klingler, M., et al. (1988). Function of torso in determining the terminal anlagen of
the Drosophila embryo. Nature 335: 275-7
Li, J., Xia, F. and Li, W. X. (2003). Coactivation of STAT and Ras is required for germ cell proliferation and invasive migration in Drosophila. Dev. Cell 5: 787-798. 14602078
Li, W., et al. (1997). The Drosophila 14-3-3 protein Leonardo enhances Torso signaling through D-Raf in a Ras 1-dependent manner. Development 124(20): 4163-4171.
Li, W. X., et al. (2002). Differential requirement for STAT by gain-of-function and wild-type receptor tyrosine kinase Torso in Drosophila
Development 129: 4241-4248. 12183376
Lia, J. and Li, W. X. (2003). Drosophila gain-of-function mutant RTK torso triggers ectopic Dpp and STAT signaling. Genetics 164: 247-258. 12750336
Liaw, G. J. and Lengyel, J. A. (1993). Control of tailless expression by bicoid, dorsal and
synergistically interacting terminal system regulatory
elements. Mech Dev 40: 47-61
Liaw, G. J., et al. (1995). The torso response element binds GAGA and NTF-1/Elf-1,
and regulates tailless by relief of repression. Genes Dev 9: 3163-3176
Lim, Y. M., et al. (1997). Dominant mutations of Drosophila MAP kinase kinase and their
activities in Drosophila and yeast MAP kinase cascades
Genetics 146 (1): 263-273.
Lloyd, T. E., et al. (2002). Hrs regulates endosome membrane invagination and tyrosine kinase receptor signaling in Drosophila. Cell 108: 261-269. 11832215
Lu, X., et al. (1993). Control of cell fate determination by p21ras/Ras1, an
essential component of torso signaling in Drosophila. Genes Dev 7: 621-32
Martin, J. R., Raibaud, A. Ollo, R. (1994). Terminal pattern elements in Drosophila embryo induced
by the torso-like protein. Nature 367: 741-5
Paroush, Z., Wainwright, S. M. and Ish-Horowicz, D. (1997). Torso signalling regulates terminal patterning in Drosophila by antagonising Groucho-mediated repression. Development 124(19): 3827-3834.
Perkins, L. A., Larsen, I and Perrimon, N. (1992). corkscrew encodes a putative protein tyrosine
phosphatase that functions to transduce the terminal
signal from the receptor tyrosine kinase torso.
Cell 70: 225-36
Pultz, M. A., Pitt, J. N. and Alto, N. M. (1999). Extensive zygotic control of the anteroposterior axis in the wasp
Nasonia vitripennis. Development 126(4): 701-710.
Radke, K., Baek, K. H. and Ambrosio, L. (1997). Characterization of maternal and zygotic D-raf proteins: dominant
negative effects on Torso signal transduction.
Genetics 145 (1): 163-171.
Ronchi, E., et al. (1993). Down-regulation of the Drosophila morphogen bicoid by
the torso receptor-mediated signal transduction cascade. Cell 74: 347-55
Rusch, J. and Levine, M. (1994). Regulation of the dorsal morphogen by the Toll and torso
signaling pathways: a receptor tyrosine kinase selectively
masks transcriptional repression. Genes Dev 8: 1247-1257
Salles, F. J., et al. (1994). Coordinate initiation of Drosophila development by
regulated polyadenylation of maternal messenger RNAs. Science 266: 1996-1999
Schaeffer, V., et al. (2000). High Bicoid levels render the terminal system dispensable for Drosophila
head development. Development 127: 3993-3999. 10952897
Schoppmeier, M. and Schr–der, R. (2005). Maternal torso signaling controls body axis elongation in a short germ insect. Current Biol. 15: 2131-2136. 16332539
Sprenger, F. Stevens, L. M. and Nusslein-Volhard, C. (1989). The Drosophila gene torso encodes a putative receptor tyrosine kinase. Nature 338: 478-83
Sprenger, F. and Nusslein-Volhard, C. (1992). Torso receptor activity is regulated by a diffusible ligand produced at the extracellular terminal regions of the Drosophila egg. Cell 71: 987-1001
Sprenger, F., Trosclair, M. M. and Morrison, D. K. (1993). Biochemical analysis of torso and D-raf during Drosophila embryogenesis: implications for terminal signal transduction. Mol Cell Biol 13: 1163-72
Strecker, T. R., et al. (1989). Reciprocal effects of hyper- and hypoactivity mutations in
the Drosophila pattern gene torso. Science 243: 1062-6
Yamaguchi, M., Nishida, Y. and Matsukage, A. (1995). Role of homeodomain protein binding region in the
expression of Drosophila proliferating cell nuclear
antigen gene: analysis with transgenic flies. Gene Expr 4: 183-193
Yip, M.L, Lamka, M. L. and Lipshitz, H. D. (1997). Control of germ-band retraction in Drosophila by the zinc-finger protein HINDSIGHT. Development 124 (11): 2129-2141.
Zhang, Q., Zheng, Q. and Lu, X. (1999). A genetic screen for modifiers of Drosophila Src42A identifies
mutations in Egfr, rolled and a novel signaling gene. Genetics 151: 697-711.
torso:
Biological Overview
| Evolutionary Homologs
| Regulation
| Protein Interactions
| Developmental Biology
| Effects of Mutation
date revised: 10 April 2008
Home page: The Interactive Fly © 1997 Thomas B. Brody, Ph.D.
The Interactive Fly resides on the
Society for Developmental Biology's Web server.